Table 2.
Treatment | % of peripheral blood lymphocytes of type: |
||
---|---|---|---|
CD3+ | CD3+ CD4+ | CD3+ CD8+ | |
PBS | 35.15 ± 2.14 | 14.36 ± 1.89 | 9.22 ± 1.51 |
AIVs | 45.99 ± 1.23 | 20.87 ± 2.13 | 13.68 ± 2.12 |
AIVs + 25 mg/kg BP5 | 48.78 ± 2.86 | 20.54 ± 1.38 | 16.87 ± 1.89 |
AIVs + 5 mg/kg BP5 | 58.82 ± 2.48* | 26.89 ± 1.56* | 22.67 ± 1.78*† |
AIVs + 1 mg/kg BP5 | 61.46 ± 1.61**† | 30.44 ± 2.24** | 25.01 ± 1.53**† |
H9N2 AIV vaccine | 56.87 ± 2.31* | 28.57 ± 1.79** | 16.51 ± 1.35 |
Chickens were sacrificed on day 28 after first immunization, and the peripheral blood lymphocytes were collected for immunophenotyping. The data presented are means ± SD of results from four replicates.
, P < 0.05, and
, P < 0.01, compared with chickens immunized with the inactivated AIVs alone.
, P < 0.05, compared with chickens immunized with the commercial H9N2 AIV vaccine.